AAAAAA

   
Results: 1-8 |
Results: 8
VISUAL CONTRAST SENSITIVITY IN CARBAMAZEPINE-RESISTANT EPILEPTIC PATIENTS RECEIVING VIGABATRIN AS ADD-ON THERAPY
Authors: SARTUCCI F MASSETANI R GALLI R BONANNI E TOGNONI G MILANI S IUDICE A MURRI L
Citation: F. Sartucci et al., VISUAL CONTRAST SENSITIVITY IN CARBAMAZEPINE-RESISTANT EPILEPTIC PATIENTS RECEIVING VIGABATRIN AS ADD-ON THERAPY, Journal of epilepsy, 10(1), 1997, pp. 7-11
A QUANTITATIVE STUDY OF DAYTIME SLEEPINESS INDUCED BY CARBAMAZEPINE AND ADD-ON VIGABATRIN IN EPILEPTIC PATIENTS
Authors: BONANNI E MASSETANI R GALLI R GNERI C PETRI M IUDICE A MURRI L
Citation: E. Bonanni et al., A QUANTITATIVE STUDY OF DAYTIME SLEEPINESS INDUCED BY CARBAMAZEPINE AND ADD-ON VIGABATRIN IN EPILEPTIC PATIENTS, Acta neurologica Scandinavica, 95(4), 1997, pp. 193-196
COMPARATIVE-STUDY OF TERFENADINE AND CETIRIZINE IN HAY-FEVER - ASSESSMENT OF EFFICACY AND CENTRAL-NERVOUS-SYSTEM EFFECTS
Authors: BONIFAZI F PROVINCIALI L ANTONICELLI L BILO MB PUCCI S SIGNORINO M FRANCIOLINI B CENSORI B PAGELLI P IUDICE A
Citation: F. Bonifazi et al., COMPARATIVE-STUDY OF TERFENADINE AND CETIRIZINE IN HAY-FEVER - ASSESSMENT OF EFFICACY AND CENTRAL-NERVOUS-SYSTEM EFFECTS, Journal of investigational allergology & clinical immunology, 5(1), 1995, pp. 40-46
EFFICACY AND TOLERABILITY OF VIGABATRIN IN CHILDREN WITH REFRACTORY PARTIAL SEIZURES - A SINGLE-BLIND DOSE-INCREASING STUDY
Authors: DALLABERNARDINA B FONTANE E VIGEVANO F FUSCO L TORELLI D GALEONE D BUTI D CIANCHETTI C GNANASAKTHY A IUDICE A
Citation: B. Dallabernardina et al., EFFICACY AND TOLERABILITY OF VIGABATRIN IN CHILDREN WITH REFRACTORY PARTIAL SEIZURES - A SINGLE-BLIND DOSE-INCREASING STUDY, Epilepsia, 36(7), 1995, pp. 687-691
VIGABATRIN AS FIRST ADD-ON TREATMENT IN CARBAMAZEPINE-RESISTANT EPILEPSY PATIENTS
Authors: MURRI L IUDICE A
Citation: L. Murri et A. Iudice, VIGABATRIN AS FIRST ADD-ON TREATMENT IN CARBAMAZEPINE-RESISTANT EPILEPSY PATIENTS, Acta neurologica Scandinavica, 92, 1995, pp. 40-42
DEFLAZACORT PROTECTS AGAINST LATE-PHASE BUT NOT EARLY-PHASE REACTIONSINDUCED BY THE ALLERGEN-SPECIFIC CONJUNCTIVAL PROVOCATION TEST
Authors: CIPRANDI G BUSCAGLIA S PESCE GP IUDICE A BAGNASCO M CANONICA GW
Citation: G. Ciprandi et al., DEFLAZACORT PROTECTS AGAINST LATE-PHASE BUT NOT EARLY-PHASE REACTIONSINDUCED BY THE ALLERGEN-SPECIFIC CONJUNCTIVAL PROVOCATION TEST, Allergy, 48(6), 1993, pp. 421-430
COMPARISON OF 2 GLUCOCORTICOID PREPARATIONS (DEFLAZACORT AND PREDNISONE) IN THE TREATMENT OF IMMUNE-MEDIATED DISEASES
Authors: SCUDELETTI M PUPPO E LANZA L MANTOVANI L BOSCO O IUDICE A IMBIMBO B INDIVERI F
Citation: M. Scudeletti et al., COMPARISON OF 2 GLUCOCORTICOID PREPARATIONS (DEFLAZACORT AND PREDNISONE) IN THE TREATMENT OF IMMUNE-MEDIATED DISEASES, European Journal of Clinical Pharmacology, 45, 1993, pp. 190000029-190000034
PROTECTIVE EFFECTS OF DEFLAZACORT ON ALLERGEN-SPECIFIC CONJUNCTIVAL CHALLENGE
Authors: CIPRANDI G BUSCAGLIA S IUDICE A PESCE GP BAGNASCO M CANONICA GW
Citation: G. Ciprandi et al., PROTECTIVE EFFECTS OF DEFLAZACORT ON ALLERGEN-SPECIFIC CONJUNCTIVAL CHALLENGE, European Journal of Clinical Pharmacology, 45, 1993, pp. 190000035-190000041
Risultati: 1-8 |